BRCA1 mutations in Brazilian patients

Genetics and Molecular Biology

Volumn 27, Issue 4, 2004, Pages 500-504

  Lourenço, Juliano Javert ^a,b   Vargas, Fernando R ^a,b   Bines, José ^a   Santos, Elizete M ^a   Lasmar, Cezar A P ^a   Costa, Célia H ^a   Teixeira, Eliane M B ^a   Maia, Maria C M ^a   Coura, Fátima ^a   Silva, Carlos H D ^a   Moreira, Miguel A M ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

BRCA1; Breast cancer; Ovarian cancer

Indexed keywords

ADENINE; BRCA1 PROTEIN; CYSTEINE; GUANINE; MESSENGER RNA; THYMINE;

ADULT; ARTICLE; BASE PAIRING; BRAZIL; BREAST CANCER; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FAMILY HISTORY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE IDENTIFICATION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC COUNSELING; HEREDITY; HUMAN; HUMAN CELL; INTRON; MALE; NUCLEIC ACID BASE SUBSTITUTION; OVARY CANCER; PATIENT SELECTION; RNA SPLICING; STOP CODON; TUMOR LOCALIZATION;

EID: 19944427635     PISSN: 14154757     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1415-47572004000400006     Document Type: Article

References (39)

1. Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N and Peretz T (1997) The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Askenazi women. Am J Hum Genet 60:505-14.
2. Alves-Silva J, Santos MS, Guimarães PEM, Ferreira ACS, Bandelt HJ, Pena SDJ and Prado VF (2000) The ancestry of Brazilian mtDNA lineages. Am J Hum Genet 67:444-461.
3. Brose MS, Rebbeck TR, Calzone KA, Stopfer JE and Weber BL (2002) Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 94:1365-1372.
4. Brown MA, Lo LJ, Catteau A, Xu CF, Lindeman GJ, Hodgson S and Solomon E (2002) Germline BRCA1 promoter deletions in UK and Australian familial breast cancer patients: Identification of a novel deletion consistent with BRCA1: psiBRCA1 recombination. Hum Mutat 19:435-442.
5. Carvalho-Silva DR, Santos FR, Rocha J and Pena SDJ (2001) The phylogeography of Brazilian Y chromosome lineages. Am J of Hum Genet 678:281-286.
6. Corvello CM, Duarte APM, Mourão-Neto M and Simpson AJG (1998) BRCA1, BRCA2 and TP53 germline mutations in Brazilian breast cancer families. Breast Cancer Res Treat 50(Suppl):297.
7. Delgado LB, Gonzalez A, Fernandez G, Cataldi S, Bressac-De Paillerets B, Bombled J, Sabini G, Roca R and Muse IM (2003) BRCA1 and BRCA2 mutations in Uruguayan breast and breast/ovarian cancer families. ASCO Annual Meeting 2003, New Orleans, USA.
8. Dong J, Claude JC, Wu Y, Schumacher V, Debatin I, Tonin P and Pokora BR (1998) A high proportion of mutations in the BRCA1 gene in German breast/ovarian cancer families with clustering of mutations in the 3′ third of the gene. Hum Genet 103:54-161.
9. Durocher F, Tonin P, Shattuck-Eidens D, Skolnick M, Narod SA and Simard J (1996) Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites. J Med Genet 33:814-819
10. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Deville P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA and Zelada-Hedman M (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676-689.
11. Foulkes WD, Brunet JS, Warner E, Goodwin PJ, Meschino W, Narod SA, Goss PE and Glendon G (1999) The importance of a family history of breast cancer in predicting the presence of a BRCA mutation. Am J Hum Genet 65:1776-1779.
12. Frank TS, Manley SA, Olopade OI, Cummings S, Garber JE, Bernhardt B, Antman K, Russo D, Wood ME, Mullineau L, Isaacs C, Peshkin B, Buys S, Venne V, Rowley PT, Loader S, Offit K, Robson M, Hampel H, Brener D, Winer EP, Clark S, Weber B, Strong LC, Rieger P, McClure M, Ward BE, Shattuck-Eidens D, Oliphant A, Skolnick MA, Thomas A (1998) Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 16:2417-2425.
13. Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowell SE and King MC (1994) Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8:399-404.
14. Gao Q, Tomlinson G, Das S, Cummings S, Sveen L, Fackenthal J, Schumm P and Olopade OI (2000) Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer. Hum Genet 107:186-91.
15. Hall MJ, Lee KM, Euman B, Morrow EJ, Anderson AL, Huey B and King CM (1990) Linkage of early-onset familial breast cancer to chromossome 17q21. Science 250:1684-1689.
16. Hamann U, Haner M, Stosiek U, Bastert G and Scott RJ (1997) Low frequency of BRCA1 germline mutations in 45 German breast/ovarian cancer families. J Med Genet 34:884-888.
17. Jara L, Ampuero S, Seccia L, Bustamante M, Blanco R and Ojeda JM (2002) Analysis of 5382insC (BRCA1) and 6174delT (BRCA2) mutations in 382 healthy Chilean women with a family history of breast cancer. Biol Res 35:85-93.
18. Kasprazak L, Foulkes WD and Shelling AN (1999) Hereditary ovarian carcinoma. BMJ 318:786-789.
19. Kinney AY, Croyle RT, Dudley WN, Bailey CA, Pelias MK and Neuhausen SL (2001) Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: A survey of a large African-American kindred with a BRCA1 mutation. Prev Med 33:43-51.
20. Langston AA, Malone KE, Thompson JD, Daling JR and Ostrander EA (1996) BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med 334:137-142.
21. Loman N, Johannsson O, Kristoffersson U, Olsson H and Borg A (2001) Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst 93:1215-23.
22. Los Rios P, Jack E, Kuperstein G, Lynch E, Lubinsky J and Narod AS (2001) Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer. Am J Hum Genet 68:546-450.
23. Martin AM, Blackwood MA, Antin-Ozerkis D, Shih HA, Calzone K, Colligon TA, Seal S, Collins N, Stratton MR, Weber BL and Nathanson KL (2001) Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic. J Clin Oncol 19:2247-53.
24. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Strano HA, Katcher H, Yakumo K, Gholami Z, Shaffer RD, Stone S, Bayer S, Wray C, Bogden R, Ward J, Narod S, Bristow KP, Helvering R, Morrison P, Rosteck P, Lai M, Lewis C, Neuhausen S, Albright CR, Wiseman R, Kamb A and Skolnick M (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71.
25. Miller SA, Dykes DD and Polesky HF (1988) A simple salting procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16:215.
26. Moller P, Borg A, Evans DG, Haites N, Reis MM, Vasen H, Anderson E, Steel CM, Apold J, Goudie D, Howell A, Lalloo F, Maehle L, Gregory H and Heimdal K (2002) Survival in prospectively ascertained familial breast cancer: Analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy. Int J Cancer 101:555-559.
27. Montagna M, Palma MD, Menin C, Agata S, De Nicolo A, Chieco-Bianchi L and D'Andrea E (2003) Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 12:1055-61.
28. Offit K (1998) Clinical Cancer Genetics - Risk, Counseling and Management. Willey Liss, New York, 419 pp.
29. Olopade OI, Fackenthal JD, Dunston G, Tainsky MA, Collins F and Whitfield-Broome C (2003) Breast cancer genetics in African-Americans. Cancer 97(Suppl. 1):236-45.
30. Panguluri RC, Brody LC, Modali R, Utley K, Adams-Campbell L, Day AA, Whitfield-Broome C and Dunston GM (1999) BRCA1 mutations in African Americans. Hum Genet 105:28-31.
31. Rohlfs EM, Puget N, Graham ML, Weber BL, Garber JE, Skrzynia C, Halperin JL, Lenoir GM, Silverman LM and Mazoyer S (2000) ALU mediated 7,1kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10. Genes Chromosomes Cancer 28:300-307.
32. Ruiz-Flores P, Sinilnikova OM, Badzioch M, Calderon-Garciduenas AL, Chopin S, Fabrice O, Gonzalez-Guerrero JF, Szabo C, Lenoir G, Goldgar DE and Barrera-Saldana HA (2002) BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico. Hum Mutat 20:474-5.
33. Shattuck-Eidens D, Oliphant A, McClure M, McBride C, Gupte J, Rubano T, Pruss D, Tavtigian SV, Teng DH, Adey N, Staebell M, Gumpper K, Lundstrom R, Hulick M, Kelly M, Holmen J, Lingenfelter B, Manley S, Fujimura F, Luce M, Ward B, Cannon-Albright L, Steele L, Offit K, Gilewski T, Norton L, Brown K, Schulz C, Hampel H, Schluger A, Giulotto E, Zoli W, Ravaioli A, Nevanlinna H, Pyrhonen S, Rowley P, Loader S, Osborne MP, Daly M, Tepler I, Weinstein PL, Scalia J, Michaelson R, Scott RJ, Radice P, Pierotti MA, Garber JE, Isaacs C, Peshkin B, Lippman ME, Dosik MH, Caligo M, Grenstein RM, Pilarski R, Weber B, Burgemeister R, Frank TS, Skolnick MH and Thomas A (1997) BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA 278:1242-1250.
34. Shen D, Wu Y, Subbarao M, Bhat H, Chillar R and Vadgama JV (2000) Mutation analysis of BRCA1 gene in African-American patients with breast cancer. J Natl Med Assoc 92:29-35.
35. Simard J, Tonin P, Durocher F, Morgan K, Rommens J, Gingras S, Samson C, Leblanc JF, Belanger C, Dion F, Liu Q, Skolnick M, Goldgar D, Shattuck-Eidens D, Labrie F and Narod S (1994) Common origin of BRCA1 mutation in Canadian breast and ovarian cancer families. Nat Genet 8:392-398.
36. Simon SD, Molina A and Moreira-Filho CA (2003) Mutations of BRCA1/2 genes in Brazil. ASCO Annual Meeting 2003, New Orleans, USA.
37. Szabo CI and King MC (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60:1013-20.
38. Trincado P, Fardella C, Mayerson D, Montero L, O'Brien A, Barrueto K and Gallegos R (1999) Prevalence of the 185Ag deletion of the BRCA1 gene in Chilean women with breast neoplasm. Rev Med Chil 127:19-22.
39. Unger MA, Nathanson KL, Calzone K, Antin-Ozerkis D, Shih HÁ, Martin AM, Lenoir GM, Mazoyer S and Weber BL (2000) Screening for genomic rearragements in families with breast and ovarian cancer identifies BRCA1 mutation previously missed by conformation-sensitive gel electrophoresis or sequencing. Am J Hum Genet 67:841-850.